The USP5-MATN3 axis in nucleus pulposus cell senescence: A deubiquitination mechanism protecting against intervertebral disc degeneration
Cellular Signalling · 2026-11 · 147 · 112746
DOI: 10.1016/j.cellsig.2026.112746 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2026-11. Verfasst von Chunyang Fan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Orthopaedic Institute, The First Affiliated Hospital of Soochow University, Suzhou Medical College, Soochow Univer…. Hauptthemen laut MEDLINE: Intervertebral Disc Degeneration, Cellular Senescence, Nucleus Pulposus, Endopeptidases. Die Arbeit nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Intervertebral disc degeneration (IVDD) is a major cause and independent risk factor for low back pain. This study aims to explore the molecular mechanisms underlying IVDD and provide new ideas for targeted treatment. Cellular senescence is a key pathological event in IVDD, but its upstream regulatory network in nucleus pulposus cells (NPCs) remains unclear. This study found that MATN3 protein expression decreased significantly during IVDD, and its level was closely associated with NPC senescence. Functionality experiment data show that overexpression of MATN3 can effectively inhibits NPC senescence in vitro and delays the pathological progression of IVDD in a rat tail puncture model. Interestingly, no significant difference was observed in MATN3 at the mRNA level. Mechanistically, immunoprecipitation-mass spectrometry and co-immunoprecipitation identified USP5 as a direct interacting protein of MATN3, which it stabilized via deubiquitination, and functional rescue experiments confirmed that USP5 alleviated NPC senescence by upregulating MATN3. In conclusion, this study clarifies the molecular mechanism by which the USP5/MATN3 axis regulates cellular senescence and affects IVDD progression, opening up new potential targets for the intervention strategy of IVDD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Orthopaedic Institute, The First Affiliated Hospital of Soochow University, Suzhou Medical College, Soochow University, Suzhou, China.
- Department of Orthopaedic Surgery, Orthopaedic Institute, The First Affiliated Hospital of Soochow University, Suzhou Medical College, Soochow University, Suzhou, China. Electronic address: wuxiexing@163.com.
- Department of Orthopaedic Surgery, Orthopaedic Institute, The First Affiliated Hospital of Soochow University, Suzhou Medical College, Soochow University, Suzhou, China. Electronic address: szgengdc@suda.edu.cn.
- Department of Orthopaedic Surgery, Orthopaedic Institute, The First Affiliated Hospital of Soochow University, Suzhou Medical College, Soochow University, Suzhou, China. Electronic address: sudamaohq@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Fan, C., Xia, J., Zhang, Y., Zhao, J., Qin, W., Zhang, J., Ling, X., Wu, X., Geng, D., & Mao, H. (2026). The USP5-MATN3 axis in nucleus pulposus cell senescence: A deubiquitination mechanism protecting against intervertebral disc degeneration. Cellular Signalling, 147, 112746. https://doi.org/10.1016/j.cellsig.2026.112746
Vancouver
Fan C, Xia J, Zhang Y, Zhao J, Qin W, Zhang J, et al. The USP5-MATN3 axis in nucleus pulposus cell senescence: A deubiquitination mechanism protecting against intervertebral disc degeneration. Cellular Signalling. 2026;147:112746. doi:10.1016/j.cellsig.2026.112746
BibTeX
@article{Fan2026,
author = {Fan, Chunyang and Xia, Jiechao and Zhang, Yao and Zhao, Jianbing and Qin, Wanjin and Zhang, Jian and Ling, Xuwei and Wu, Xiexing and Geng, Dechun and Mao, Haiqing},
title = {The USP5-MATN3 axis in nucleus pulposus cell senescence: A deubiquitination mechanism protecting against intervertebral disc degeneration},
journal = {Cellular Signalling},
year = {2026},
volume = {147},
pages = {112746},
doi = {10.1016/j.cellsig.2026.112746}
}
EUVIMED